{
    "clinical_study": {
        "@rank": "57026", 
        "arm_group": [
            {
                "arm_group_label": "laparoscopic ovarian cystectomy", 
                "description": "the group who laparoscopic ovarian cystectomy are performed for endometrioma"
            }, 
            {
                "arm_group_label": "laparoscopic  non- ovarian pelvic surgery", 
                "description": "the group whom laparoscopic  non- ovarian pelvic surgery are performed"
            }
        ], 
        "brief_summary": {
            "textblock": "This aim of the study is to evaluate the impact of endometrioma and laparoscopic cystectomy\n      on ovarian reserve as measured by serum antimullerian hormone and to study the different\n      effects of  levels of serum antimullerian hormone between laparoscopic cystectomy and the\n      non-ovarian pelvic surgery."
        }, 
        "brief_title": "Anti-Mullerian Hormone Changes After Laparoscopic Ovarian Cystectomy for Endometrioma Compared With the Non-ovarian Conditions", 
        "condition": "Ovarian Reserve", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2022 Participants must be between the ages of 18 - 45 during enter the study  .\n\n               -  Every participants have to completely understand the process of this study and\n                  have written informed consent .\n\n               -  Having regular menstrual cycles (21-35 days) at the time of operation\n\n               -  no evidence of any other endocrine disorders such as diabetes mellitus, thyroid\n                  dysfunction, hyperprolactinemia, congenital adrenal hyperplasia, Cushing's\n                  syndrome, or adrenal insufficiency.\n\n               -  undergo laparoscopic ovarian cystectomy or  laparoscopic non- ovarian pelvic\n                  surgery for benign pelvic disease\n\n               -  No previous history of adnexal surgery\n\n               -  No any suspicious findings of malignant ovarian diseases\n\n               -  Never   taking any medication such as oral pill and hormonal drugs within 3\n                  months before the enrollment.\n\n               -  pathological diagnosis of excised ovarian tissue confirm as endometriotic cyst\n                  in study group and other benign pelvic disease in control group\n\n        Exclusion Criteria:\n\n          -  polycystic ovarian syndrome according to the Rotterdam criteria\n\n               -  pathological report as the  malignant diseases\n\n               -  have operation conversion to open-laparotomy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Reproductive women , age 18- 45 years who  undergo laparoscopic ovarian cystectomy or\n        laparoscopic  non- ovarian pelvic surgery"
            }
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01919333", 
            "org_study_id": "MTU-OB-3-096/56"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 6, 2013", 
        "location": {
            "contact": {
                "email": "chamnandoctor@gmail.com", 
                "last_name": "Chamnan Tanprasertkul", 
                "phone": "66896999240"
            }, 
            "facility": {
                "address": {
                    "city": "Rangsit", 
                    "country": "Thailand", 
                    "state": "Pathumthanee", 
                    "zip": "12120"
                }, 
                "name": "Faculty of medicine , Thammasat university"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_groups": "2", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Serum AMH levels", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01919333"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Thammasat University", 
            "investigator_full_name": "Chamnan Tanprasertkul", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Thammasat University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Thammasat University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}